O'Shea DF - Search Results

1

A potent nonporphyrin class of photodynamic therapeutic agent: cellular localisation, cytotoxic potential and influence of hypoxia.

Gallagher WM, Allen LT, O'Shea C, Kenna T, Hall M, Gorman A, Killoran J, O'Shea DF. Gallagher WM, et al. Br J Cancer. 2005 May 9;92(9):1702-10. doi: 10.1038/sj.bjc.6602527. Br J Cancer. 2005. PMID: 15841085 Free PMC article.

2

Synthesis of BF2 chelates of tetraarylazadipyrromethenes and evidence for their photodynamic therapeutic behaviour.

Killoran J, Allen L, Gallagher JF, Gallagher WM, O'Shea DF. Killoran J, et al. Chem Commun (Camb). 2002 Sep 7;(17):1862-3. doi: 10.1039/b204317c. Chem Commun (Camb). 2002. PMID: 12271646

3

In vitro demonstration of the heavy-atom effect for photodynamic therapy.

Gorman A, Killoran J, O'Shea C, Kenna T, Gallagher WM, O'Shea DF. Gorman A, et al. J Am Chem Soc. 2004 Sep 1;126(34):10619-31. doi: 10.1021/ja047649e. J Am Chem Soc. 2004. PMID: 15327320

4

A modular synthesis of unsymmetrical tetraarylazadipyrromethenes.

Hall MJ, McDonnell SO, Killoran J, O'Shea DF. Hall MJ, et al. J Org Chem. 2005 Jul 8;70(14):5571-8. doi: 10.1021/jo050696k. J Org Chem. 2005. PMID: 15989339

5

Supramolecular photonic therapeutic agents.

McDonnell SO, Hall MJ, Allen LT, Byrne A, Gallagher WM, O'Shea DF. McDonnell SO, et al. J Am Chem Soc. 2005 Nov 30;127(47):16360-1. doi: 10.1021/ja0553497. J Am Chem Soc. 2005. PMID: 16305199

6

PET modulated fluorescent sensing from the BF2 chelated azadipyrromethene platform.

Hall MJ, Allen LT, O'Shea DF. Hall MJ, et al. Org Biomol Chem. 2006 Mar 7;4(5):776-80. doi: 10.1039/b514788c. Epub 2006 Jan 19. Org Biomol Chem. 2006. PMID: 16493459

7

Impact of a conformationally restricted receptor on the BF2 chelated azadipyrromethene fluorosensing platform.

Killoran J, O'Shea DF. Killoran J, et al. Chem Commun (Camb). 2006 Apr 14;(14):1503-5. doi: 10.1039/b513878g. Epub 2006 Feb 27. Chem Commun (Camb). 2006. PMID: 16575441

8

Creation of a digital slide and tissue microarray resource from a multi-institutional predictive toxicology study in the rat: an initial report from the PredTox group.

Mulrane L, Rexhepaj E, Smart V, Callanan JJ, Orhan D, Eldem T, Mally A, Schroeder S, Meyer K, Wendt M, O'Shea D, Gallagher WM. Mulrane L, et al. Exp Toxicol Pathol. 2008 Aug;60(4-5):235-45. doi: 10.1016/j.etp.2007.12.004. Epub 2008 May 13. Exp Toxicol Pathol. 2008. PMID: 18479893

9

Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment.

Byrne AT, O'Connor AE, Hall M, Murtagh J, O'Neill K, Curran KM, Mongrain K, Rousseau JA, Lecomte R, McGee S, Callanan JJ, O'Shea DF, Gallagher WM. Byrne AT, et al. Br J Cancer. 2009 Nov 3;101(9):1565-73. doi: 10.1038/sj.bjc.6605247. Epub 2009 Oct 13. Br J Cancer. 2009. PMID: 19826417 Free PMC article.

10

Light induced antimicrobial properties of a brominated boron difluoride (BF(2)) chelated tetraarylazadipyrromethene photosensitizer.

Frimannsson DO, Grossi M, Murtagh J, Paradisi F, O'Shea DF. Frimannsson DO, et al. J Med Chem. 2010 Oct 28;53(20):7337-43. doi: 10.1021/jm100585j. J Med Chem. 2010. PMID: 20879783

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters